Common Stock, Shares, Outstanding of IOVANCE BIOTHERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 411,938,061, a 35% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 411,938,061 +106,685,867 +35% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 385,461,728 +80,841,258 +27% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 341,919,364 +44,613,365 +15% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 333,934,387 +54,178,048 +19% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 305,252,194 +49,116,479 +19% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 304,620,470 +48,786,791 +19% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 297,305,999 +72,617,565 +32% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 279,756,339 +55,397,360 +25% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 256,135,715 +68,323,643 +36% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 255,833,679 +97,993,098 +62% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 224,688,434 +66,887,853 +42% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 224,358,979 +67,190,658 +43% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 187,812,072 +30,807,330 +20% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 157,840,581 +1,137,928 +0.73% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 157,800,581 +3,000,860 +1.9% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 157,168,321 +7,853,022 +5.3% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 157,004,742 +9,129,825 +6.2% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 156,702,653 +10,121,029 +6.9% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 154,799,721 +8,364,911 +5.7% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 149,315,299 +22,492,143 +18% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 147,874,917 +21,463,109 +17% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 146,581,624 +20,388,634 +16% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 146,434,810 +22,614,302 +18% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 126,823,156 +3,428,043 +2.8% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 126,411,808 +2,996,232 +2.4% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 126,192,990 +28,767,269 +30% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 123,820,508 +31,078,836 +34% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 123,395,113 +33,779,696 +38% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 123,415,576 +50,250,662 +69% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 97,425,721 +25,470,878 +35% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 92,741,672 +30,061,282 +48% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 89,615,417 +27,265,268 +44% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 73,164,914 +10,916,840 +18% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 71,954,843 +10,006,454 +16% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 62,680,390 +4,291,485 +7.4% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 62,350,149 +13,833,621 +29% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 62,248,074 +13,700,354 +28% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 61,948,389 +14,140,991 +30% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 58,388,905 +11,248,710 +24% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 48,516,528 +3,644,640 +8.1% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 48,547,720 +14,797,532 +44% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 47,807,398 +20,167,710 +73% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 47,140,195 +19,913,845 +73% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 44,871,888 +22,778,930 +103% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 33,750,188 +13,726,230 +69% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q3 2014 27,639,688 +12,566,777 +83% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 27,226,350 +13,894,035 +104% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 22,092,958 +21,274,152 +2598% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 20,023,958 +19,205,152 +2346% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 15,072,911 -63,220,184 -81% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 13,332,315 -64,960,780 -83% 30 Jun 2013 10-Q 23 Oct 2013 2013 Q2
Q1 2013 818,806 -77,474,289 -99% 31 Mar 2013 10-Q 23 Oct 2013 2013 Q1
Q4 2012 818,806 -77,174,785 -99% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 78,293,095 +4,654,746 +6.3% 30 Sep 2012 10-Q 25 Jan 2013 2012 Q3
Q2 2012 78,293,095 +629,746 +0.81% 30 Jun 2012 10-Q/A 10 Sep 2012 2012 Q2
Q1 2012 78,293,095 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 77,993,591 +4,355,242 +5.9% 31 Dec 2011 10-K 23 Sep 2013 2012 FY
Q3 2011 73,638,349 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q2 2011 77,663,349 30 Jun 2011 10-Q/A 01 Sep 2011 2011 Q2
Q4 2010 73,638,349 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.